Citadel Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Sell
616,800
-38,000
-6% -$7.79M 0.02% 767
2025
Q4
$168M Sell
654,800
-578,500
-47% -$152M 0.03% 567
2025
Q3
$321M Buy
1,233,300
+301,600
+32% +$79.3M 0.05% 314
2025
Q2
$228M Sell
931,700
-119,200
-11% -$29.7M 0.04% 370
2025
Q1
$278M Buy
1,050,900
+21,200
+2% +$5.73M 0.05% 272
2024
Q4
$261M Sell
1,029,700
-189,800
-16% -$50.9M 0.05% 305
2024
Q3
$386M Buy
1,219,500
+503,000
+70% +$179M 0.07% 183
2024
Q2
$268M Sell
716,500
-454,700
-39% -$154M 0.05% 265
2024
Q1
$406M Buy
1,171,200
+284,300
+32% +$108M 0.08% 167
2023
Q4
$406M Buy
886,900
+488,000
+122% +$241M 0.08% 147
2023
Q3
$194M Sell
398,900
-1,100
-0.3% -$517K 0.04% 320
2023
Q2
$179M Sell
400,000
-87,700
-18% -$44.2M 0.04% 358
2023
Q1
$237M Sell
487,700
-119,600
-20% -$59.1M 0.05% 258
2022
Q4
$311M Buy
607,300
+212,700
+54% +$112M 0.07% 192
2022
Q3
$191M Buy
394,600
+165,100
+72% +$80.3M 0.04% 318
2022
Q2
$107M Buy
229,500
+13,400
+6% +$5.96M 0.03% 538
2022
Q1
$94M Sell
216,100
-34,400
-14% -$14.4M 0.02% 692
2021
Q4
$116M Sell
250,500
-23,200
-8% -$10.3M 0.02% 577
2021
Q3
$107M Buy
273,700
+94,300
+53% +$40M 0.02% 623
2021
Q2
$79.4M Buy
179,400
+6,200
+4% +$2.71M 0.02% 807
2021
Q1
$72.6M Sell
173,200
-38,300
-18% -$15.3M 0.02% 767
2020
Q4
$86.8M Buy
211,500
+19,300
+10% +$8.02M 0.02% 631
2020
Q3
$79.5M Sell
192,200
-127,700
-40% -$51.4M 0.02% 584
2020
Q2
$124M Buy
319,900
+150,100
+88% +$56.2M 0.04% 326
2020
Q1
$53.3M Sell
169,800
-22,600
-12% -$7.62M 0.02% 610
2019
Q4
$70.5M Buy
192,400
+9,700
+5% +$3.08M 0.03% 574
2019
Q3
$46.7M Buy
182,700
+10,400
+6% +$2.92M 0.02% 797
2019
Q2
$45.7M Buy
172,300
+22,600
+15% +$5.73M 0.02% 780
2019
Q1
$39.8M Buy
149,700
+17,800
+13% +$5.13M 0.02% 831
2018
Q4
$37.8M Sell
131,900
-4,800
-4% -$1.52M 0.02% 776
2018
Q3
$46.3M Buy
136,700
+46,300
+51% +$15M 0.02% 806
2018
Q2
$26.9M Sell
90,400
-81,000
-47% -$23.7M 0.01% 1082
2018
Q1
$46.1M Sell
171,400
-13,800
-7% -$3.74M 0.03% 640
2017
Q4
$45.9M Buy
185,200
+116,400
+169% +$28.7M 0.03% 657
2017
Q3
$16.8M Buy
68,800
+17,100
+33% +$4.19M 0.01% 1199
2017
Q2
$12.4M Sell
51,700
-23,300
-31% -$5.28M 0.01% 1290
2017
Q1
$15.5M Buy
75,000
+54,100
+259% +$11.2M 0.01% 1129
2016
Q4
$4.26M Sell
20,900
-5,700
-21% -$1.09M ﹤0.01% 2161
2016
Q3
$4.71M Sell
26,600
-6,400
-19% -$1.11M ﹤0.01% 2050
2016
Q2
$5.94M Buy
33,000
+11,300
+52% +$2.01M 0.01% 1675
2016
Q1
$3.97M Sell
21,700
-24,100
-53% -$4.18M 0.01% 1976
2015
Q4
$8.18M Sell
45,800
-46,100
-50% -$8.09M 0.01% 1428
2015
Q3
$16.4M Sell
91,900
-110,900
-55% -$20.5M 0.02% 1017
2015
Q2
$38.8M Buy
202,800
+121,400
+149% +$22.5M 0.03% 610
2015
Q1
$14.5M Sell
81,400
-28,200
-26% -$4.46M 0.01% 1180
2014
Q4
$15.7M Buy
109,600
+44,300
+68% +$6.05M 0.02% 1105
2014
Q3
$8.51M Sell
65,300
-14,800
-18% -$1.88M 0.01% 1490
2014
Q2
$10.2M Sell
80,100
-51,200
-39% -$6.06M 0.01% 1250
2014
Q1
$14.8M Buy
131,300
+43,500
+50% +$4.53M 0.02% 1029
2013
Q4
$9.06M Sell
87,800
-9,700
-10% -$950K 0.01% 1267
2013
Q3
$9.1M Sell
97,500
-3,400
-3% -$312K 0.01% 1154
2013
Q2
$8.51M Buy
+100,900
New +$7.96M 0.01% 1172

Other funds holding HUM

Citadel Advisors's HUM Position: Q1 2026 in Review

Citadel Advisors increased its Humana (HUM) stake by 320% in Q1 2026, buying an estimated $22.1M and bringing the position to 141,650 shares worth $24.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Citadel Advisors first reported a position in HUM in Q2 2013 and has held it in 50 quarters since. The position peaked at $774M in Q3 2023. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Citadel Advisors held 141,650 shares of Humana worth $24.6M as of Q1 2026.
  • Citadel Advisors bought 107,899 Humana shares in Q1 2026, an estimated $22.1M.
  • Humana made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2083 holding.
  • Citadel Advisors first reported a position in Humana in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Humana position peaked at $774M in Q3 2023.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.